Citadel Advisors
IRMD icon

Citadel Advisors’s iRadimed IRMD Stock Holding History

Citadel Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$927K Sell
9,700
-5,000
-34% -$455K ﹤0.01% 8386
2026
Q1 		$1.42M Buy
+14,700
New +$1.47M ﹤0.01% 6853
2025
Q1 		– Sell
-600
Closed -$33K – 15008
2024
Q4 		$33K Buy
+600
New +$31.6K ﹤0.01% 12784
2024
Q3 		– Sell
-1,600
Closed -$70.3K – 14715
2024
Q2 		$70.3K Sell
1,600
-800
-33% -$34K ﹤0.01% 11371
2024
Q1 		$106K Hold
2,400
– – ﹤0.01% 11282
2023
Q4 		$114K Buy
+2,400
New +$101K ﹤0.01% 10765

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors's IRMD Position: Q2 2026 in Review

Citadel Advisors sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 32,504 shares — an estimated $2.96M sold.

Citadel Advisors first reported a position in IRMD in Q1 2020 and held it in 17 quarters. The position peaked at $5.42M in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Citadel Advisors reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 32,504 iRadimed shares in Q2 2026, an estimated $2.96M.
  • Citadel Advisors first reported a position in iRadimed in Q1 2020 and held it in 17 quarters.
  • Citadel Advisors's iRadimed position peaked at $5.42M in Q4 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.